ATE266387T1 - Lyophilisate mit verbesserter rekonstituierbarkeit - Google Patents

Lyophilisate mit verbesserter rekonstituierbarkeit

Info

Publication number
ATE266387T1
ATE266387T1 AT00906226T AT00906226T ATE266387T1 AT E266387 T1 ATE266387 T1 AT E266387T1 AT 00906226 T AT00906226 T AT 00906226T AT 00906226 T AT00906226 T AT 00906226T AT E266387 T1 ATE266387 T1 AT E266387T1
Authority
AT
Austria
Prior art keywords
lyophilizates
improved
reconstitutability
improved reconstitutability
lyophilisates
Prior art date
Application number
AT00906226T
Other languages
German (de)
English (en)
Inventor
Thekla Kurz
Ludwig Krueger
Brigitte Hesse
Arnd Karnatz
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of ATE266387T1 publication Critical patent/ATE266387T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00—Drying solid materials or objects by processes not involving the application of heat
    • F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
    • F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/402—1-aryl substituted, e.g. piretanide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Waveguide Aerials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT00906226T 1999-01-28 2000-01-26 Lyophilisate mit verbesserter rekonstituierbarkeit ATE266387T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19903275A DE19903275A1 (de) 1999-01-28 1999-01-28 Lyophilisate mit verbesserter Rekonstituierbarkeit
PCT/EP2000/000569 WO2000044354A1 (de) 1999-01-28 2000-01-26 Lyophilisate mit verbesserter rekonstituierbarkeit

Publications (1)

Publication Number Publication Date
ATE266387T1 true ATE266387T1 (de) 2004-05-15

Family

ID=7895601

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00906226T ATE266387T1 (de) 1999-01-28 2000-01-26 Lyophilisate mit verbesserter rekonstituierbarkeit

Country Status (21)

Country Link
US (1) US6770678B1 (https=)
EP (1) EP1146863B1 (https=)
JP (2) JP4562288B2 (https=)
KR (1) KR20010108136A (https=)
AT (1) ATE266387T1 (https=)
AU (1) AU757781B2 (https=)
BR (1) BRPI0007714B8 (https=)
CA (1) CA2361237C (https=)
CZ (1) CZ20012693A3 (https=)
DE (2) DE19903275A1 (https=)
DK (1) DK1146863T3 (https=)
ES (1) ES2220404T3 (https=)
HU (1) HU226585B1 (https=)
NO (1) NO331321B1 (https=)
PL (1) PL351140A1 (https=)
PT (1) PT1146863E (https=)
RU (1) RU2225709C2 (https=)
SK (1) SK10542001A3 (https=)
UA (1) UA70351C2 (https=)
WO (1) WO2000044354A1 (https=)
ZA (1) ZA200107081B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7227033B2 (en) * 2002-01-09 2007-06-05 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate
DE102004045825A1 (de) * 2004-09-22 2006-03-23 Merck Patent Gmbh Lyophilisat enthaltend N-Diaminomethylen-2-methyl-4,5-di-(methylsulfonyl)-benzamid
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
RU2299063C1 (ru) * 2006-03-03 2007-05-20 Федеральное государственное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии имени Г.Н. Габричевского Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека" (ФГУН МНИИЭМ им. Г.Н. Габричевского Роспотребнадзора) Способ сушки термолабильного биологически активного препарата
AU2009243749B2 (en) 2008-05-09 2013-11-21 Merck Patent Gmbh Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction
EP2346826A2 (en) * 2008-06-09 2011-07-27 AWD.pharma GmbH & Co.KG Carboxylic acid salts of 2-amino-3-carbethoxyamino-6-(4-fluoro-benzylamino)-pyridine
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
US10584123B2 (en) * 2017-09-27 2020-03-10 Fedora Pharmaceuticals Inc. Pharmaceutical forms of diazabicyclooctane derivatives and manufacturing method thereof
EP3733182A4 (en) * 2017-12-28 2021-09-01 FUJIFILM Toyama Chemical Co., Ltd. PROCESS FOR PREPARING A FREEZE-DRIED FORMULATION

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002748A (en) * 1976-01-19 1977-01-11 Eli Lilly And Company Method of preparing sterile essentially amorphous cefazolin for reconstitution for parenteral administration
JPH07114946B2 (ja) * 1988-10-24 1995-12-13 株式会社奈良機械製作所 難溶性物質の処理方法
US5066647A (en) * 1989-04-20 1991-11-19 Erbamont, Inc. Cyclophosphamide - alanine lyophilizates
DE59305042D1 (de) * 1992-09-22 1997-02-20 Hoechst Ag Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika
JP2747967B2 (ja) 1993-07-23 1998-05-06 雪印乳業株式会社 シアル酸粉末
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
RU2105569C1 (ru) * 1995-06-05 1998-02-27 Индивидуальное частное предприятие Фирма "Брынцалов" Способ получения лекарственной формы противоопухолевого антибиотика
DE19529612A1 (de) * 1995-08-11 1997-02-13 Merck Patent Gmbh Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate
RU2111426C1 (ru) * 1995-11-03 1998-05-20 Государственный научный центр вирусологии и биотехнологии "Вектор" Способ лиофильной сушки биопрепарата
JPH09183729A (ja) * 1995-12-29 1997-07-15 Meiji Milk Prod Co Ltd 凍結乾燥ウラシルを含有する抗腫瘍医薬組成物

Also Published As

Publication number Publication date
CA2361237A1 (en) 2000-08-03
JP2010264249A (ja) 2010-11-25
JP2002535089A (ja) 2002-10-22
NO331321B1 (no) 2011-11-21
NO20013703D0 (no) 2001-07-27
US6770678B1 (en) 2004-08-03
RU2225709C2 (ru) 2004-03-20
BR0007714A (pt) 2001-11-27
AU757781B2 (en) 2003-03-06
EP1146863B1 (de) 2004-05-12
DE50006404D1 (de) 2004-06-17
CZ20012693A3 (cs) 2002-01-16
HUP0105493A2 (en) 2002-06-29
ZA200107081B (en) 2003-02-26
PT1146863E (pt) 2004-10-29
ES2220404T3 (es) 2004-12-16
BR0007714B1 (pt) 2014-09-30
KR20010108136A (ko) 2001-12-07
DK1146863T3 (da) 2004-08-30
BRPI0007714B8 (pt) 2021-05-25
NO20013703L (no) 2001-07-27
PL351140A1 (en) 2003-03-24
UA70351C2 (en) 2004-10-15
EP1146863A1 (de) 2001-10-24
JP4562288B2 (ja) 2010-10-13
SK10542001A3 (sk) 2002-01-07
HU226585B1 (en) 2009-04-28
DE19903275A1 (de) 2000-08-03
CA2361237C (en) 2008-07-15
WO2000044354A1 (de) 2000-08-03
HUP0105493A3 (en) 2006-07-28
AU2798600A (en) 2000-08-18

Similar Documents

Publication Publication Date Title
AP1771A (en) 3'-Prodrugs of 2'-deoxy-?-L-nucleosides.
DE60024581D1 (de) 6-phenylphenanthridine mit pde-iv hemmender wirkung
ATE266387T1 (de) Lyophilisate mit verbesserter rekonstituierbarkeit
DK2130554T3 (da) Albuminfrie faktor VIII-præparater
TR199901238T2 (xx) Asalak �ld�r�c� olarak 3-thiokarbamoylpirazol t�revleri.
DE69909246D1 (de) Hemmung der menschlichen telomerase durch g-quadruplex interaktionverbindung
BR0009163A (pt) Vacina
PT1157030E (pt) Complexos equinocandina/hidrato de carbono
ATE356810T1 (de) Polysubstituted 6-phenylphenanthridines mit pde- iv hemmender wirkung
ATE550618T1 (de) Wärmeübertrageranordnung
DE60041184D1 (de) Staubsaugergebläse mit gleichmässiger strömung
PL343176A1 (en) Fungicidal 6-(2-halo-4-alkoxyphenyl)-triazolopyrimidines
TR200401363T4 (tr) DNA viral enfeksiyonlarının tedavisi
ATE295352T1 (de) Phenanthridine-n-oxide mit pde-iv hemmender wirkung
USD461171S1 (en) Semiconductor device
ATE342957T1 (de) Waschmittelformkörper mit viskoelastischer phase
DK1023903T3 (da) Anvendelse af levende, svækkede bakterier til fremstilling af en submukös vaccine
FR2798875B1 (fr) Pince reglable manipulable a une seule main
NO20025303L (no) Anvendelse av substituerte akryloyl-distamycin-derivater i behandlingen avtumorer assosiert med höye nivåer av glutation
USD459317S1 (en) Semiconductor device
USD459316S1 (en) Semiconductor device
DE50109975D1 (de) Wäscheschirm
DE50000282D1 (de) Einrichtung zum gegenseitigen Verriegeln von gruppierbaren Möbeln
IT1318113B1 (it) Dispositivo per l'allineamento, con disposizione rettilinea dei bordi, di pacchetti di pezzi in lavorazione rettangolari piatti.
Guiying et al. Preliminary studies on the cause of southern flood and northern drought during the summer of 1999 in China